Pfizer, BioNTech seek emergency use authorization for COVID-19 vaccine
02:31
Share this -
copied
Pfizer and its German partner BioNTech are the first companies to seek emergency use authorization for their COVID-19 vaccine, believed to be 95% effective. Moderna is expected to follow suit soon. These vaccine candidates may be on the fast track for approval, but there are still hurdles to cross with the Food and Drug Administration. NBC’s Kathy Park reports for Weekend TODAY.Nov. 21, 2020
UP NEXT
Rob Gronkowski reveals his pick to win Super Bowl 2023
05:59
Al Roker tries his hand at making TikTok-famous Coke floats
04:12
Jay Leno breaks several bones in motorcycle accident
02:10
Police K9 ‘arrested’ after sandwich in break room disappears
00:42
NASA pays tribute to all astronauts lost over the decades
02:33
Alex Murdaugh trial: Jury sees body cam video, hears 911 call